The only hope now is approval from FDA. However, Novartis is a big enough company with smart enough minds to assess the risk/reward than most retail investors in this domain.
I was sad to sell it in low 2s but looks like I dodged a bigger bullet. Good luck to the holders.
Ann: Update on Novartis Agreement, page-39
-
- There are more pages in this discussion • 812 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.20 |
Change
0.010(0.84%) |
Mkt cap ! $1.358B | |||
| Open | High | Low | Value | Volume |
| $1.18 | $1.20 | $1.18 | $818.3K | 688.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 19 | 53694 | $1.20 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.20 | 232204 | 29 |
View Market Depth
| Last trade - 10.37am 15/07/2024 (20 minute delay) ? |
| MSB (ASX) Chart |